米力农
医学
变向性
心力衰竭
重症监护医学
心脏病学
内科学
急性失代偿性心力衰竭
血流动力学
心输出量
多巴酚丁胺
心力衰竭的处理
左旋西孟旦
缓和医疗
药物治疗
心脏病
作者
Cristian Castillo‐Rodriguez,Michel Juarez,Diego Cruz,Ben Thiravetyan,Chanokporn Puchongmart,Sherif Roman,Mahmoud Abdelnabi,William H. Frishman,Wilbert S. Aronow
标识
DOI:10.1097/crd.0000000000001075
摘要
Positive inotropic agents have an important role in the management of acute decompensated heart failure patients with reduced cardiac output and poor end-organ perfusion. However, despite their acute hemodynamic benefits, the role of inotropes in the management of chronic advanced heart failure remains limited to palliative therapy or as a bridging strategy to mechanical support or heart transplantation. Milrinone is one of the most common inotropic agents used in advanced heart failure to provide symptomatic relief and improved hemodynamics. This review discusses the current evidence of milrinone's efficacy, indications, outcomes in advanced heart failure, evidence gap, and future directions.
科研通智能强力驱动
Strongly Powered by AbleSci AI